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The A2A adenosine receptor is a G protein-coupled recep-
tor which desensitizes upon prolonged agonist stimula-
tion. In order to understand the biological function of its
unusually long C-terminus, we screened a human brain
library for proteins capable of binding to the last 120
amino acids of the A2A receptor. We identified a guanine
nucleotide exchange factor for the small G protein ARF6
(ARNO/cytohesin-2) as a binding partner. In this study,
we investigated the impact of ARNO on A2A receptor sign-
aling in rat pheochromocytoma (PC12) cells. These cells
express the A2A receptors endogenously. We created cell
lines with inducible expression of ARNO or its catalytic
inactive mutant E156K. Neither wild type ARNO nor the
mutant had an effect on receptor expression, signaling via
adenylyl cyclase after activation or long-term de- and
resensitization kinetics. In order to investigate effects of
ARNO on A2A receptor short-term de- and resensitization
we employed a FRET-based sensor to measure changes in
cAMP in real time. Cells were transfected with plasmids
encoding the regulatory and catalytic subunit of protein
kinase A (PKA) fused to CFP and YFP, respectively. Accu-
mulation of cAMP results in the dissociation of the PKA
subunits, which can be measured in single cells as a loss
of FRET. The presence of dominant negative ARNO accel-
erated the recovery of A2A receptor after stimulation and
led to a pronounced signaling response when cells were
re-challenged with agonist. While membrane recruitment
of ARNO was not affected by the mutation, we observed a
difference in the recovery of the A2A receptor after agonist
treatment. Our results indicate that the interaction with
ARNO/cytohesin-2 stabilizes short-term desensitization
of the A2A receptor to prevent excessive stimulation.
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